Draegerwerk AG & Co. KGaA stock analysis
Draegerwerk AG & Co. KGaA (0MT8) Share Price & Analysis
0MT8 Stock Chart & Stats
- Day’s Range
- EUR 80.00 - EUR 86.20
- 52-Week Range
- EUR 55.20 - EUR 95.80
- Previous Close
- EUR 84.00
- Volume
- N/A
- Average Volume (3M)
- 561
- Market Cap
- EUR 1.82B
- Enterprise Value
- EUR 1.68B
- Total Cash (Recent Filing)
- EUR 270.90M
- Total Debt (Recent Filing)
- EUR 228.93M
- Price to Earnings (P/E)
- 12.3
- Beta
- 0.73
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 11, 2026
- Dividend Yield
- 2.58%
Bulls Say, Bears Say
Bulls Say
Balance Sheet And Cash Generation
Stronger operating and free cash flow gives Dräger greater capacity to fund product development, support its installed base, and reduce financial obligations. Conservative leverage adds resilience, allowing the company to pursue growth while relying less on external financing during weaker cycles.
Safety Segment Momentum
The Safety division is demonstrating broad demand and improving profitability across product areas and regions. This segment’s growth, together with its recurring detection, respiratory protection, and service opportunities, can provide a durable earnings foundation as investment in workplace and public safety continues.
FDA Regulatory Resolution
Removal of the FDA warning letter resolves a long-standing regulatory constraint and reduces the resources required for remediation work. It should improve Dräger’s ability to pursue product approvals and commercial opportunities, strengthening the Medical segment’s long-term operating platform.
Bears Say
Medical Segment Still Loss-Making
Medical remains a meaningful drag on consolidated profitability despite year-over-year improvement. Continued losses indicate that scale, pricing, mix, or cost actions have not yet produced a durable turnaround, leaving group margins dependent on sustained Safety performance and further Medical execution.
Expense And Tariff Pressure
Expense growth above the pace of underlying sales can erode margin recovery and requires continued cost discipline. Higher personnel, logistics, IT, and freight costs, combined with unrecovered U.S. customs expenses, create an ongoing risk that operational gains will not fully convert into earnings.
China And Regional Demand Weakness
Weak Chinese demand and declines in selected regions make growth less balanced across Dräger’s global markets. Prolonged softness could delay Medical recovery, reduce capacity utilization, and require additional commercial or cost measures, particularly if stronger regions cannot consistently offset the shortfall.
0MT8 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
What is Draegerwerk AG & Co. KGaA’s market cap?
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Is Draegerwerk AG & Co. KGaA overvalued?
Does Draegerwerk AG & Co. KGaA pay dividends?
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
What is the TipRanks Smart Score and how is it calculated?
Draegerwerk AG & Co. KGaA Stock Smart Score
Company Description
Draegerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and markets comprehensive system solutions, equipment, and support services tailored for acute care environments. This encompasses emergency services, surgical procedures (perioperative care), intensive care units (critical care), and specialized newborn care (perinatal care). Their extensive product portfolio includes items such as anesthesia machines, respiratory ventilators, temperature management devices, monitoring systems for patients, and associated software and consumables. For safety applications, the company delivers essential products, integrated systems, and services designed for personal protection, sophisticated gas detection, and holistic hazard management. These offerings cater to industrial and mining operations, as well as public safety organizations like fire brigades, police forces, and disaster relief agencies. Key safety products range from fixed and portable gas sensing equipment to personal protective gear and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs, comprehensive service packages, and even dedicated fire training facilities for emergency responders.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Stefan A. Drager
- Employees
- 16,687
- Website
- www.draeger.com
- Address
- Moislinger Allee 53-55, Lübeck, SH, 23542, DE
Draegerwerk AG & Co. KGaA (0MT8) Earnings & Revenues
0MT8 Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Dräger reported strong nine-month order intake, sales, earnings, cash flow, balance-sheet improvement and Safety division momentum, confirmed full-year guidance, and highlighted the lifting of the FDA warning letter and opportunities in defense. These positives were tempered by third-quarter EBIT and Medical performance declines, higher functional expenses, a negative net tariff effect, weaker China demand, Americas and APAC pressure in specific areas, and the need for tight fourth-quarter cost management.
View all GB:0MT8 earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 2 | 5 |
| Technical Analysis | 3 | 2 | 5 |
| Moving Averages | 12 | 0 | 0 |








